EP 4132964 A2 20230215 - DE NOVO PROTEIN DECOYS OF ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2)
Title (en)
DE NOVO PROTEIN DECOYS OF ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2)
Title (de)
DE NOVO PROTEIN-KÖDER DES ANGIOTENSIN-KONVERTIERENDEN ENZYMS 2 (ACE2)
Title (fr)
LEURRES PROTÉIQUES DE NOVO DE L'ENZYME 2 DE CONVERSION DE L'ANGIOTENSINE (ACE2)
Publication
Application
Priority
- US 202063006463 P 20200407
- US 202063028401 P 20200521
- US 202062705150 P 20200613
- US 202063055051 P 20200722
- US 202063060489 P 20200803
- US 202063094179 P 20201020
- US 202163145352 P 20210203
- US 2021025974 W 20210406
Abstract (en)
[origin: WO2021207207A2] Provided herein are de novo protein decoys of ACE2 and uses thereof. In some embodiments, methods of treating coronavirus infection using the ACE2 protein decoys are provided.
IPC 8 full level
C07K 14/705 (2006.01); A61K 38/00 (2006.01); A61P 31/14 (2006.01); C12N 9/48 (2006.01)
CPC (source: EP KR)
A61K 38/4813 (2013.01 - KR); A61K 45/06 (2013.01 - EP KR); A61P 31/14 (2017.12 - EP KR); C07K 14/70596 (2013.01 - EP); C12N 9/485 (2013.01 - EP KR); A61K 38/00 (2013.01 - EP); C12Y 304/17023 (2013.01 - KR)
Citation (search report)
See references of WO 2021207207A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021207207 A2 20211014; WO 2021207207 A3 20211125; AU 2021251760 A1 20221006; CA 3173628 A1 20211014; CN 115515972 A 20221223; EP 4132964 A2 20230215; JP 2023521706 A 20230525; KR 20220164736 A 20221213
DOCDB simple family (application)
US 2021025974 W 20210406; AU 2021251760 A 20210406; CA 3173628 A 20210406; CN 202180029294 A 20210406; EP 21721753 A 20210406; JP 2022560982 A 20210406; KR 20227036446 A 20210406